Downregulation of BCL2 by AT-101 enhances the antileukaemic effect of lenalidomide both by an immune dependant and independent manner-Reference-Cited by-同舟云学术

Downregulation of BCL2 by AT-101 enhances the antileukaemic effect of lenalidomide both by an immune dependant and independent manner

Published:2011-12-15 Issue:1 Volume:157 Page:59-66
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Masood Aisha,Chitta Kasyapa,Paulus Aneel,Khan A. Nazmul H.,Sher Taimur,Ersing Noreen,Miller Kena C.,Manfredi Deborah,Ailawadhi Sikander,Borrelo Ivan,Lee Kelvin P.,Chanan-Khan Asher

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.2011.08984.x/fullpdf

Reference32 articles.

1. A phase II, open label study of AT-101 in combination with rituximab in patients with relapsed or refractory chronic lymphocytic leukemia;Castro;Blood (ASH Annual Meeting Abstracts),2006

2. A phase II, open label study of AT-101 in combination with rituximab in patients with relapsed or refractory chronic lymphocytic leukemia. evaluation of two dose regimens;Castro;Blood (ASH Annual Meeting Abstracts),2007

3. Bcl-2 antisense therapy in B-cell malignancies;Chanan-Khan;Blood Reviews,2005

4. Lenalidomide for the treatment of B-cell malignancies;Chanan-Khan;Journal of Clinical Oncology,2008

5. Immunomodulating drugs for chronic lymphocytic leukaemia;Chanan-Khan;The Lancet Oncology,2006

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lactic acid: The culprit behind the immunosuppressive microenvironment in hepatocellular carcinoma;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09

2. AT-101 Enhances the Antitumor Activity of Lenalidomide in Patients with Multiple Myeloma;Cancers;2023-01-12

3. Updates in the Use of BCL-2-Family Small Molecule Inhibitors for the Treatment of Relapsed/Refractory Multiple Myeloma;Cancers;2022-07-08

4. Targeting Bcl-2 for cancer therapy;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2021-08

5. Potential Utility of Natural Killer Cells for Eliminating Cells Harboring Reactivated Latent HIV-1 Following the Removal of CD8+ T Cell-Mediated Pro-Latency Effect(s);Viruses;2021-07-26